Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Large-scale testing (Phase 3)Study completedNCT00771563
What this trial is testing

Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Antwerp 104
Large-scale testing (Phase 3)Active Not RecruitingNCT06295731
What this trial is testing

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc 410
Testing effectiveness (Phase 2)UnknownNCT04466254
What this trial is testing

Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 75
Testing effectiveness (Phase 2)Looking for participantsNCT04602377
What this trial is testing

Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT

Who this might be right for
Small Cell Ovarian Carcinoma
ARCAGY/ GINECO GROUP 27
Testing effectiveness (Phase 2)Ended earlyNCT00452075
What this trial is testing

Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
Rigshospitalet, Denmark 24
Testing effectiveness (Phase 2)UnknownNCT05574998
What this trial is testing

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial

Who this might be right for
Non-Small-Cell Lung Cancer
Qianfoshan Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00493636
What this trial is testing

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Who this might be right for
Breast Cancer
Accelerated Community Oncology Research Network 160
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Testing effectiveness (Phase 2)Study completedNCT03432598
What this trial is testing

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

Who this might be right for
Locally Advanced Lung Cancer; Metastatic Lung Cancer
BeiGene 54
Large-scale testing (Phase 3)Active Not RecruitingNCT06711900
What this trial is testing

SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 432
Large-scale testing (Phase 3)Study completedNCT02445209
What this trial is testing

Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma

Who this might be right for
HER2 Negative Gastric Cancer
Jagiellonian University 56
Testing effectiveness (Phase 2)UnknownNCT04973904
What this trial is testing

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Peking Union Medical College Hospital 35
Very early researchUnknownNCT06208033
What this trial is testing

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
EGFR Positive Non-small Cell Lung Cancer
Fujian Cancer Hospital 40
Post-approval studies (Phase 4)UnknownNCT03571126
What this trial is testing

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Who this might be right for
Chemotherapy-induced Nausea and VomitingLung Cancer
Zunyi Medical College 156
Testing effectiveness (Phase 2)UnknownNCT04976647
What this trial is testing

HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC

Who this might be right for
Squamous Non-small-cell Lung Cancer
Shanghai Henlius Biotech 156
Large-scale testing (Phase 3)Study completedNCT01355484
What this trial is testing

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Muscle WastingNon Small Cell Lung Cancer
GTx 321
Large-scale testing (Phase 3)Ended earlyNCT03516084
What this trial is testing

Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 185
Large-scale testing (Phase 3)Study completedNCT00205764
What this trial is testing

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 212
Large-scale testing (Phase 3)Looking for participantsNCT07544654
What this trial is testing

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

Who this might be right for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Boehringer Ingelheim 390
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation